|
IFT57 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.70240044283787E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.10849999682239E-08 |
| Normal-vs-Stage2 |
4.14050000000499E-05 |
| Normal-vs-Stage3 |
4.4009995647798E-10 |
| Normal-vs-Stage4 |
7.99615929025776E-12 |
| Stage1-vs-Stage2 |
4.254200E-01 |
| Stage1-vs-Stage3 |
5.282000E-02 |
| Stage1-vs-Stage4 |
1.482370E-03 |
| Stage2-vs-Stage3 |
5.955400E-01 |
| Stage2-vs-Stage4 |
1.724620E-01 |
| Stage3-vs-Stage4 |
2.372400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.29310007146444E-10 |
| Normal-vs-AfricanAmerican |
2.217700E-02 |
| Normal-vs-Asian |
3.991600E-04 |
| Caucasian-vs-AfricanAmerican |
3.114600E-01 |
| Caucasian-vs-Asian |
1.097010E-01 |
| AfricanAmerican-vs-Asian |
9.060400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.13739997817686E-09 |
| Normal-vs-Female |
8.67690030936785E-10 |
| Male-vs-Female |
3.686600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.87410000243682E-08 |
| Normal-vs-Age(41-60Yrs) |
2.98160000022918E-08 |
| Normal-vs-Age(61-80Yrs) |
1.73180358942204E-11 |
| Normal-vs-Age(81-100Yrs) |
6.47649999999667E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.577000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.230500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.414600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.062400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.545400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.789200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.564600E-03 |
| Classical-VS-Follicular |
2.676000E-03 |
| Classical-VS-Other |
2.483800E-01 |
| Classical-VS-Normal |
2.1191000000309E-06 |
| Tall-VS-Follicular |
5.040200E-01 |
| Tall-VS-Other |
6.969400E-01 |
| Tall-VS-Normal |
1.11309994554887E-09 |
| Follicular-VS-Other |
9.826600E-01 |
| Follicular-VS-Normal |
8.49569969929576E-10 |
| Other-VS-Normal |
1.863240E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.33050023723536E-10 |
| Normal-vs-N1 |
2.17980000716267E-09 |
| N0-vs-N1 |
3.651800E-01 |
|
|
